Skip to content

Evolutionary Genomics, Inc.

CIK 0000884363

← back to feed
Revenue (TTM)
$95.98K
−89.8% YoY FY Mar 2023
Net Income (TTM)
−$2.66M
+30.7% YoY FY Mar 2023
EPS Diluted (TTM)
−$0.47
+32.7% YoY FY Mar 2023
Gross Margin
121.2%
FY Mar 2023
Operating Margin
-2,859.5%
FY Mar 2023
Net Margin
-2,771.4%
FY Mar 2023
Free Cash Flow (TTM)
−$632.46K
FY Mar 2023
Cash
$577.07K
FY Mar 2023
Total Debt
$3.74M
FY Mar 2023
Shares Outstanding
6.66M sh
FY Mar 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings